Aytu BioPharma (AYTU) Fiscal Q4 2026 Earnings Call: EXXUA Growth and FY2027 Outlook
Source Tradingkey
Key Takeaways
- Aytu BioPharma reported fiscal Q4 2026 net revenue of $16.1 million, up 6% year over year and from $12.4 million in fiscal Q3. Full-year net revenue was $57.6 million.
- EXXUA generated $3.9 million of Q4 net revenue, up from $2.4 million in Q3. Quarterly prescriptions rose to 3,323 from 1,398, while 4,599 units were shipped.
- The company returned to positive quarterly adjusted EBITDA of $0.5 million, versus a $2.8 million loss in Q3. Q4 net loss narrowed to $0.1 million.
- Cash remained relatively stable at $26.3 million as of June 30, 2026, despite debt reduction. Aytu generated $3.3 million of operating cash flow for fiscal 2026 and subsequently repaid the remaining revolving credit balance.
- Management expects fiscal 2027 GAAP operating expenses of $49 million to $54 million and cash-based operating expenses of $45 million to $49 million. It expects the six months ending June 30, 2027, to generate positive adjusted EBITDA.
- EXXUA prescriptions continued rising after quarter-end, reaching 1,377 in July, 1,408 in August, and a weekly record of 394 for the week ended September 4.
Key Financial Data
| Metric | Fiscal Q4 2026 | Comparison / context |
|---|---|---|
| Net revenue | $16.1 million | Up 6% from $15.1 million a year earlier; Q3 was $12.4 million |
| EXXUA net revenue | $3.9 million | Up from $2.4 million in Q3 |
| ADHD portfolio revenue | $10.4 million | $13.1 million a year earlier; $9.1 million in Q3 |
| Pediatrics revenue | $1.8 million | $2.0 million a year earlier; $0.9 million in Q3 |
| Gross profit | $10.4 million | $10.3 million a year earlier |
| Gross margin | Approximately 65% | 68% a year earlier and 61% in Q3 |
| Operating expenses | $11.2 million | $17.9 million a year earlier, including an $8.3 million prior-year impairment charge |
| Net loss | $0.1 million | $19.8 million loss a year earlier |
| Adjusted EBITDA | $0.5 million | $2.0 million a year earlier; negative $2.8 million in Q3 |
| Cash and cash equivalents | $26.3 million | $26.7 million at March 31 and $31.0 million at fiscal 2025 year-end |
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
Bitcoin falls below $75,000 as the CLARITY Act fails in the Senate — what the vote means for cryptoThe US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.
The US Senate blocked the Digital Asset Market CLARITY Act in a 49-50 procedural vote, sending Bitcoin briefly below $75,000 — its biggest one-day drop since June. Ethereum fell more than 8%, Coinbase slid 10% and $75 billion of crypto market value evaporated. Here is what the vote was, why it failed, and the levels that matter now.
Dollar index tops 100 for the first time since July as the Fed's hawkish dot plot sinks inThe U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.
The U.S. dollar index broke back above 100 for the first time since 31 July after the Fed delivered its first rate hike since 2023, with the dot plot showing 16 of 18 officials expect at least one more increase this year. Here are the levels that matter for DXY, the currencies feeling it most, and what to watch next.
Gold ends three-week slide at the $4,400 line — eight straight days of ETF inflows vs a 5% 10-year and a 100 dollarSpot gold closed Friday at $4,378.39, up 0.84% on the day and about 0.8% for the week — its first weekly gain in four weeks — with the intraday high of $4,399.67 leaving it 33 cents shy of the $4,400 line. Gold ETFs have now logged eight straight sessions of inflows, but with the 10-year back above 5% and the dollar index near 100, here is what decides whether this is a reversal or a bounce.
Spot gold closed Friday at $4,378.39, up 0.84% on the day and about 0.8% for the week — its first weekly gain in four weeks — with the intraday high of $4,399.67 leaving it 33 cents shy of the $4,400 line. Gold ETFs have now logged eight straight sessions of inflows, but with the 10-year back above 5% and the dollar index near 100, here is what decides whether this is a reversal or a bounce.
As of the Asian session on September 21, gold prices (XAUUSD) maintained high-level consolidation intraday today following a strong rebound last week, with the latest price trading around
Dollar holds above 100 near a 3-month high — three Fed speakers and a $69 billion auction land tonightThe dollar index closed at 100.43 on Monday, its highest close since late July, after a weekly gain of about 1% — the best in more than three months — and is holding above the 100.00 handle in Asia. Three Fed officials speak tonight alongside a $69 billion two-year note auction, the first leg of $183 billion of Treasury supply this week.
The dollar index closed at 100.43 on Monday, its highest close since late July, after a weekly gain of about 1% — the best in more than three months — and is holding above the 100.00 handle in Asia. Three Fed officials speak tonight alongside a $69 billion two-year note auction, the first leg of $183 billion of Treasury supply this week.
